![The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes | Scientific Reports The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-65353-x/MediaObjects/41598_2020_65353_Fig1_HTML.png)
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes | Scientific Reports
![Diagnostics | Free Full-Text | Comparison of HE4, CA125, ROMA and CPH-I for Preoperative Assessment of Adnexal Tumors Diagnostics | Free Full-Text | Comparison of HE4, CA125, ROMA and CPH-I for Preoperative Assessment of Adnexal Tumors](https://pub.mdpi-res.com/diagnostics/diagnostics-12-00226/article_deploy/html/images/diagnostics-12-00226-g001.png?1642585573)
Diagnostics | Free Full-Text | Comparison of HE4, CA125, ROMA and CPH-I for Preoperative Assessment of Adnexal Tumors
![Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download](https://slideplayer.com/slide/6626598/23/images/3/Introduction+%28cont%E2%80%99d%29.jpg)
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download
![Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1746-1596-8-11/MediaObjects/13000_2012_Article_730_Fig1_HTML.jpg)
Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text
![Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1e28ef43-c740-4fed-8a87-890cd2491360/ntbl004.jpg)
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
![Cureus | The Diagnostic Accuracy of Serum and Urine Human Epididymis Protein 4 (HE4) in Ovarian Cancer in 15,394 Subjects: An Updated Meta-Analysis | Article Cureus | The Diagnostic Accuracy of Serum and Urine Human Epididymis Protein 4 (HE4) in Ovarian Cancer in 15,394 Subjects: An Updated Meta-Analysis | Article](https://assets.cureus.com/uploads/figure/file/450386/lightbox_47ac61c04e1611ed866f3f2f10f68ed1-Figure-1.png)
Cureus | The Diagnostic Accuracy of Serum and Urine Human Epididymis Protein 4 (HE4) in Ovarian Cancer in 15,394 Subjects: An Updated Meta-Analysis | Article
![Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum - ScienceDirect Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0039914020302824-fx1.jpg)
Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum - ScienceDirect
![Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer](https://www.frontiersin.org/files/Articles/364491/fonc-08-00124-HTML/image_m/fonc-08-00124-g001.jpg)
Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer
![Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science](http://www.eurekaselect.com/images/graphical-abstract/cdt/21/10/006.jpg)
Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science
![HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125 Levels are Elevated - Denise da Rocha Pitta, Luis Otávio Sarian, Elisabete Aparecida Campos, Liliana Lucci De Angelo Andrade, Luis HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125 Levels are Elevated - Denise da Rocha Pitta, Luis Otávio Sarian, Elisabete Aparecida Campos, Liliana Lucci De Angelo Andrade, Luis](https://journals.sagepub.com/cms/10.5301/JBM.5000029/asset/images/large/10.5301_jbm.5000029-fig2.jpeg)
HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125 Levels are Elevated - Denise da Rocha Pitta, Luis Otávio Sarian, Elisabete Aparecida Campos, Liliana Lucci De Angelo Andrade, Luis
![Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy](https://www.mdpi.com/diagnostics/diagnostics-13-00452/article_deploy/html/images/diagnostics-13-00452-g001-550.jpg)